Back
Sarepta Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
110.51
Seasonality Move:
16.38%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.05 | Buy |
| 20-day SMA: | 119.95 | Sell |
| 50-day SMA: | 122.58 | Sell |
| 200-day SMA: | 130.17 | Sell |
| 8-day EMA: | 110.83 | Buy |
| 20-day EMA: | 116.6 | Sell |
| 50-day EMA: | 122.63 | Sell |
| 200-day EMA: | 126.32 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.05 | Sell |
| Relative Strength Index (14 RSI): | 37.69 | Sell |
| Chaikin Money Flow: | 693876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Sarepta Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 110.86 while SRPT 8-day simple moving average is 110.05, which is a Buy signal.
- The stock price of SRPT is 110.86 while Sarepta Therapeutics 20-day SMA is 119.95, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 122.58 while SRPT share price is 110.86, making it a Sell technically.
- SRPT stock price is 110.86 and Sarepta Therapeutics 200-day simple moving average is 130.17, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $110.86. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
10.59B
Price in USD:
110.86
Share Volume:
1.13M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
78.67
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 110.86 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 110.86 while SRPT 8-day exponential moving average is 110.83, which is a Buy signal.
- The stock price of SRPT is 110.86 while Sarepta Therapeutics 20-day EMA is 116.60, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 122.63 while SRPT share price is 110.86, making it a Sell technically.
- SRPT stock price is 110.86 and Sarepta Therapeutics 200-day simple moving average is 126.32, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.72 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -5.05, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 37.69, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is ( - ), which suggest Sarepta Therapeutics is a Buy
- The Bollinger Bands (100) for Sarepta Therapeutics is ( - ), which suggest Sarepta Therapeutics is a Buy
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.